Cyclophosphamide exposure in pediatric systemic lupus erythematosus is associated with reduced serum anti-mullerian hormone levels

J Rheumatol. 2013 Jun;40(6):1029-31. doi: 10.3899/jrheum.130017.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adolescent
  • Anti-Mullerian Hormone / blood*
  • Cyclophosphamide / therapeutic use*
  • Female
  • Humans
  • Immunosuppressive Agents / therapeutic use*
  • Lupus Erythematosus, Systemic / blood
  • Lupus Erythematosus, Systemic / drug therapy*
  • Risk Factors
  • Young Adult

Substances

  • Immunosuppressive Agents
  • Anti-Mullerian Hormone
  • Cyclophosphamide